Controlled release formulation of lamotrigine

Details Controlled release formulation of lamotrigine Controlled release formulation of lamotrigine

2011-05-10

2011-05-10

Wax, Robert A (Department: 1615)

Drug, bio-affecting and body treating compositions

Preparations characterized by special physical form

Tablets, lozenges, or pills

Reexamination Certificate

active

07939102

ABSTRACT:
Rapidly disintegrating multiparticulate controlled release formulations of lamotrigine having an improved pharmacokinetic profile and improved patient compliance, and process of preparing the formulations. It provides better control of blood plasma levels than conventional tablet formulations that is administered once or more times a day.

REFERENCES:
patent: 5326570 (1994-07-01), Rudnic et al.
patent: 5536507 (1996-07-01), Abramowitz et al.
patent: 5556639 (1996-09-01), Fielden
patent: 5637320 (1997-06-01), Bourke et al.
patent: 5863558 (1999-01-01), Jao et al.
patent: 6194000 (2001-02-01), Smith et al.
patent: 6627223 (2003-09-01), Percel et al.
patent: 2002/0012675 (2002-01-01), Jain et al.
patent: 2004/0192690 (2004-09-01), Buxton et al.
patent: 2005/0032799 (2005-02-01), Buxton et al.
patent: WO 92/13527 (1992-08-01), None
patent: WO 97/14415 (1997-04-01), None
patent: WO03090693 (2003-11-01), None

Affiliated with

Also associated with

Rating

Controlled release formulation of lamotrigine does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Controlled release formulation of lamotrigine, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Controlled release formulation of lamotrigine will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2632230